Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRMD
#2746
CorMedix Inc. - Common Stock
8.3
2
USD
-0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.95%
Monthly Change
-6.62%
6 month change
+17.35%
Year Change
-26.37%
Previous Close
8.4
0
Open
8.3
2
Low
8.3
2
High
8.3
2
Volume
76
Markets
US Stock Market
Healthcare
Biotechnology
CRMD
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
67.82 M
74.65 M
78.79 M
79.05 M
78.45 M
78.45 M
Valuation ratios
Enterprise value
351.51 M
760.37 M
1.16 B
775.41 M
354.6 M
518.41 M
Price to earnings ratio
24.64
15.79
5.56
5.7
3.13
4.09
Price to sales ratio
4.71
6.63
3.83
0
0
0.01
Price to cash flow ratio
-21.62
32.28
11.35
0.01
0.01
0.01
Price to book ratio
1.26
1.7
1.04
0
0
0
Enterprise value to EBITDA ratio
23.39
15.2
10.38
4.32
1.44
2.1
Profitability ratios
Return on assets %
0.14
0.08
0.14
0.02
0.05
0.05
Return on equity %
0.18
0.09
0.29
0.03
0.09
0.09
Return on invested capital %
225.66
250.94
142.32
10.95
34.64
34.64
Gross margin %
95.91
95.31
89.26
83.43
82.5
82.5
Operating margin %
51.5
49.18
49.24
45.97
49.96
49.96
EBITDA margin %
51.91
49.72
56.55
64.87
66.31
66.31
Net margin %
52.82
49.9
104.11
10.9
30.29
30.29
Liquidity ratios
Quick ratio
3.99
7.52
1.73
1.94
2.74
2.74
Current ratio
4.21
7.82
1.94
2.11
2.98
2.98
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.29
0.2
0.21
0.16
0.16
0.16
Solvency ratios
Debt to assets ratio
—
—
0.39
0
—
—
Debt to equity ratio
—
—
0.79
0
—
—
Long term debt to total assets ratio
—
—
-0.01
-0
—
—
Long term debt to total equity ratio
—
—
-0.01
-0
—
—
Per share metrics
Operating cash flow per share
0.29
0.42
0.36
1 176.24
0.46
1 177.47
EBIT per share
0.29
0.27
0.64
863.8
0.8
865.5
EBITDA per share
0.29
0.27
0.68
1 038.9
0.91
1 040.77
Total debt per share
—
—
3.42
11.09
—
—
Cash per share
1.12
2.65
0.65
1 849.52
1.92
1.92
Net current asset value per share
2.1
3.45
3.01
4 570.54
4.12
4.12
Tangible book value per share
1.67
3.07
4.34
5 046.91
4.7
4.7
Working capital per share
1.6
3.01
1.46
2 400.53
2.74
2.74
Book value per share
1.67
3.07
4.34
5 046.91
4.7
4.7
News
Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates
Exelixis, Inc. (EXEL) Hit a 52 Week High, Can the Run Continue?
CRMD's Growth Story Expands Beyond DefenCath Into New Trends
Is CRMD Stock a Buy Now After Strong Growth and New Risks?
CRMD Stock Outlook as DefenCath and Rezzayo Expand Growth Path
CRMD Q1 Earnings Beat on DefenCath Momentum, Guidance Raised
CorMedix Inc. (CRMD) Q1 2026 Earnings Call Transcript
CorMedix (CRMD) Q1 Earnings and Revenues Beat Estimates
Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates
Maze Therapeutics, Inc. (MAZE) Reports Q1 Loss, Beats Revenue Estimates
The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates
CorMedix (CRMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release